Sonal Dubey

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (47)

• DYRK1A Signaling in the Brain: Molecular Mechanisms and Neurotransmitter Regulation
  Current Neurovascular Research 2026 DOI: 10.2174/0115672026453723260618053839
  +Save
• From Molecules to Minds: Redefining the Power of Psychedelics and Entactogens in Treating Brain Disorders
  CNS & Neurological Disorders - Drug Targets 2026 DOI: 10.2174/0118715273452468260729080541
  +Save
• From “Undruggable” to Tractable: Therapeutic Advances Targeting KRAS G12C-Mutant Cancers and Emerging Resistance Mechanisms
  Cancer Pathogenesis and Therapy 2026 DOI: 10.1016/j.cpt.2026.02.001
  +Save
• Integrative Insights Into DYRK1A From Molecular Function to Therapeutic Advancement
  Chemical Biology & Drug Design 2026 DOI: 10.1111/cbdd.70366
  +Save
• Benzimidazole as a Versatile Scaffold for Developing Neurotherapeutics Against Neurodegenerative Diseases
  ChemMedChem 2026 DOI: 10.1002/cmdc.202500869
  +Save
• Current Advancement of Enzymatic Targets for the Mitigation of Neurodegenerative Disorders
  2025 DOI: 10.4018/979-8-3373-4627-4.ch009
  +Save
• An Innovative Dissolution Method for In-Vitro Release Assessment of Fixed-Dose Combination Tablets of Norfloxacin and Tinidazole
  Journal of Pharmaceutical Innovation 2025 DOI: 10.1007/s12247-025-10102-8
  +Save
• A systematic review of natural products targeting Nrf2-Keap1-ARE pathway and their influence on neurodegenerative disorders
  Inflammopharmacology 2025 DOI: 10.1007/s10787-025-01917-5
  +Save
• Targeting Metabolic Dysregulation in Alzheimer's Disease: A Potential Therapeutic Strategy.
  Current drug metabolism 2025 DOI: 10.2174/0113892002408089250912080734
  +Save
• Evaluation of CDK6 Inhibitory Potential of 16-(Substituted)-Dehydroepiandrosterone Derivatives Using Computational Tools
  Asian Journal of Biological Sciences 2023 DOI: 10.3923/ajbs.2023.401.408
  +Save